DILIsym Awarded $1.5 Million Phase II NIH Grant

Stock Information for Simulations Plus Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Simulations Plus Inc.

Simulations Plus Upgrades Flagship GastroPlus
Cognigen Launches KIWI Version 4.0
PMDA Adds Licenses of GastroPlus®
U.S. FDA Renews DILIsym Software Licenses
Simulations Plus to Present at B. Riley FBR Investor Conference on May 22, 2019
Lisa LaVange, PhD, Appointed to Board of Directors of Simulations Plus
FDA Purchases Bundle of ADMET Predictor® Licenses
Simulations Plus Releases ADMET Predictor® Version 9.5

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.